Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × UNKNOWN × Endocrine × Clear all

Phase

Status

Sponsor Class

OTHER 203 OTHER_GOV 19 INDUSTRY 14 NIH 4 UNKNOWN 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 53 Breast 40 Thoracic 23 Lymphoid 10 Head & Neck 10 Other hematologic neoplasm 4 Gynecologic 4 CNS 4 Tumor-Agnostic 3 Sarcoma 3 Other solid neoplasm 2 Genitourinary 2 Other neoplasm 1 NET 1 Myeloid 1 Endocrine 1

Conditions

Extrapancreatic Neuroendocrine Tumor 1

Interventions

Thalidomide 1 Temozolomide 1 Tegafur 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03204032 2017-06-29

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor

ChineseAMS

Phase 2 Unknown

EndocrineGastrointestinalNET

Extrapancreatic Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡